GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down
PharmaVoice
JULY 7, 2025
Estimates vary for how many patients with either obesity or diabetes stop using the drugs, but one 2024 study pegged the discontinuation between 50% and 75% within a year. Discontinuation rates soar The high rate of discontinuation among GLP-1 users remains a prime burden to keeping patients on the drugs.
Let's personalize your content